Multiple Sclerosis
A Areas medical research research area page covering state of the field, key trials running, recent readouts and what is close to approval, alongside the 3
STAT Launches Initiative to Address Trust in Science
STAT introduces a new initiative focused on trust in science, hiring Nicholas Florko as a dedicated reporter to explore misinformation, its origins...
FDA Clears Bristol Myers Squibb's Oral Multiple Myeloma Therapy, Introducing First-in-Class Agent
The U.S. FDA has approved Bristol Myers Squibb’s oral drug iberdomide, marketed as Zenbexus, for use with daratumumab and dexamethasone in patients...
FDA Approves Bristol Myers Squibb’s Zenbexus for Advanced Multiple Myeloma, Marking Debut of New Drug Class
The U.S. FDA has approved Zenbexus, Bristol Myers Squibb’s oral treatment for advanced multiple myeloma, introducing a new class of blood cancer...